Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · IEX Real-Time Price · USD
1.090
-0.010 (-0.91%)
Jul 22, 2024, 9:55 AM EDT - Market open
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 208 employees as of December 31, 2023. The number of employees increased by 11 or 5.58% compared to the previous year.
Employees
208
Change (1Y)
11
Growth (1Y)
5.58%
Revenue / Employee
$286,798
Profits / Employee
$32,923
Market Cap
80.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
DBV Technologies | 105 |
Chimerix | 72 |
BioAtla | 65 |
PMV Pharmaceuticals | 63 |
Ikena Oncology | 43 |
SCYNEXIS | 29 |
Genenta Science | 14 |
Nutriband | 13 |
PLX News
- 5 weeks ago - Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout - PRNewsWire
- 5 weeks ago - SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm - Accesswire
- 7 weeks ago - Protalix BioTherapeutics to Present at the 2024 BIO International Convention - PRNewsWire
- 2 months ago - Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results - PRNewsWire
- 2 months ago - Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024 - PRNewsWire
- 4 months ago - Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results - PRNewsWire
- 4 months ago - Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 - PRNewsWire
- 5 months ago - Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference - PRNewsWire